THIS PAGE IS STILL UNDER CONSTRUCTION. PLEASE DO NOT USE THIS INFORMATION YET
Related Pages
How to look up whether a drug can cause QTc prolongation or torsades
What to do about the risk of QT prolongation with methadone
Three SSRIs that may cause QT prolongation
Doesn’t escitalopram cause QTc prolongation?
Can mirtazapine increase the risk of QT prolongation?
Antipsychotics and QTc prolongation
Antibiotics, antipsychotics, and QTc prolongation
Lithium’s effects on the electrocardiogram (ECG, EKG)
What to do about the risk of arrhythmias with lamotrigine
Do modafinil/ armodafinil need cardiovascular monitoring?
What should we do about the risk of QT prolongation with methadone?
Ondansetron (Zofran®), QT prolongation, and psychotropic medications
Cytochrome P450 3A4: Substrates, inhibitors, and inducers
References
Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9. PMID: 19392907.
Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects. J Addict Dis. 2008;27(3):31-5. doi: 10.1080/10550880802122596. PMID: 18956527.
Behzadi M, Joukar S, Beik A. Opioids and Cardiac Arrhythmia: A Literature Review. Med Princ Pract. 2018;27(5):401-414. doi: 10.1159/000492616. Epub 2018 Aug 2. PMID: 30071529; PMCID: PMC6244110.
Cataldo M. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration. Addiction. 2016 Sep;111(9):1685-6. doi: 10.1111/add.13411. Epub 2016 Jun 8. PMID: 27273625.
de Jong IM, de Ruiter GS. Buprenorphine as a safe alternative to methadone in a patient with acquired long QT syndrome: a case report. Neth Heart J. 2013 May;21(5):249-52. doi: 10.1007/s12471-011-0073-9. PMID: 22020456; PMCID: PMC3636332.
Esses JL, Rosman J, Do LT, Schweitzer P, Hanon S. Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes. J Interv Card Electrophysiol. 2008 Nov;23(2):117-9. doi: 10.1007/s10840-008-9280-8. Epub 2008 Aug 7. PMID: 18686025.
Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up. J Addict Dis. 2013;32(3):244-51. doi: 10.1080/10550887.2013.824333. PMID: 24074190.
Hanon S, Seewald RM, Yang F, Schweitzer P, Rosman J. Ventricular arrhythmias in patients treated with methadone for opioid dependence. J Interv Card Electrophysiol. 2010 Jun;28(1):19-22. doi: 10.1007/s10840-009-9465-9. Epub 2010 Feb 23. PMID: 20177760.
Harris SC, Morganroth J, Ripa SR, Thorn MD, Colucci S. Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials. Postgrad Med. 2017 Jan;129(1):69-80. doi: 10.1080/00325481.2017.1270156. PMID: 27927048.
Isbister GK, Brown AL, Gill A, Scott AJ, Calver L, Dunlop AJ. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings. Br J Clin Pharmacol. 2017 Oct;83(10):2274-2282. doi: 10.1111/bcp.13326. Epub 2017 Jun 14. PMID: 28488266; PMCID: PMC5595951.
Kao DP, Haigney MC, Mehler PS, Krantz MJ. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration. Addiction. 2015 Sep;110(9):1468-75. doi: 10.1111/add.13013. PMID: 26075588; PMCID: PMC4521976.
Schmith VD, Curd L, Lohmer LRL, Laffont CM, Andorn A, Young MA. Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder. Clin Pharmacol Ther. 2019 Sep;106(3):576-584. doi: 10.1002/cpt.1406. Epub 2019 Apr 8. PMID: 30801681; PMCID: PMC6766787.
Sessler NE, Walker E, Chickballapur H, Kacholakalayil J, Coplan PM. Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data. Postgrad Med. 2017 Jan;129(1):62-68. doi: 10.1080/00325481.2016.1271698. PMID: 27977317.
Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O. Corrected QT interval during treatment with methadone and buprenorphine–relation to doses and serum concentrations. Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93. doi: 10.1016/j.drugalcdep.2012.09.016. Epub 2012 Oct 16. PMID: 23084592.
Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med. 2007 Dec 10;167(22):2469-75. doi: 10.1001/archinte.167.22.2469. PMID: 18071169.
Copyright © 2021, Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.